What is Journey Medical Corporation's EBITDA margin?

Journey Medical Corporation (DERM) reported EBITDA margin of -3.1% in Q1 2026.

What is the long-term trend for Journey Medical Corporation's EBITDA margin?

Over 3 years (2021 to 2025), Journey Medical Corporation's EBITDA margin has grown at a -51.4% compound annual growth rate (CAGR), from -55.2% to -6.3%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Journey Medical Corporation DERM EBITDA margin

EBITDA margin at other companies

Bausch Health CompaniesBHC

17%-11.8pp

Cumberland PharmaceuticalsCPIX

-6.7%-10.4pp

PTH

Pelthos Therapeutics Inc.PTHS

-145.4%—

Arcutis Biotherapeutics, Inc.ARQT

-10.5%-5.0pp

HRO

HarrowHROW

8%+5.0pp

Catalyst PharmaceuticalCPRX

51.2%+0.9pp

Other financials

Income statement

See full

Revenue$16.0M+21.5%

Gross profit$9.7M+16.7%

Operating income-$1.5M+55.1%

Net income-$2.2M+45.2%

EPS (diluted)-$0.08+55.6%

Balance sheet

See full

Cash & equivalents$27.2M+29.2%

Total debt$25.5M+1.2%

Total equity$30.8M+43.1%

Total assets$91.5M+7.7%

Cash flow

See full

Operating cash flow$2.9M+203%

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation

See full

Market cap$194.94M+20.9%

Enterprise value$193.19M+16.2%

P/S3×+0.2×

Profitability

See full

Gross margin65.4%-1.0pp

Operating margin-9.8%—

Net margin-14.8%—

FCF margin-43%—

Returns & leverage

See full

Return on equity-36.6%—

Debt / equity0.8×-0.3×

Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

ebitda/total revenue=-3.1%

Based on trailing twelve months.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Journey Medical Corporation's EBITDA margin?: Journey Medical Corporation (DERM) reported EBITDA margin of -3.1% in Q1 2026.
What is the long-term trend for Journey Medical Corporation's EBITDA margin?: Over 3 years (2021 to 2025), Journey Medical Corporation's EBITDA margin has grown at a -51.4% compound annual growth rate (CAGR), from -55.2% to -6.3%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.